Because it hasn't been released as an ASX announcement (LINK), seems to have been released as a worldwide media news release (LINK). Not sure why, would have thought an ASX/US price sensitive announcement with a media release at the same time was the way to go. Anyway, I guess the people responsible know what they're doing.
Also, noted this in the news release:
"HEMGENIX is still currently under assessment by other regulatory agencies."
I'm assuming this means other countries, so more to come in the way of revenue.
And:
LINK
News: CSL CSL Behring Will Begin Commercializing Hemgenix Immediately In The U.S. With A List Price..., page-9
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$289.10 |
Change
1.140(0.40%) |
Mkt cap ! $139.7B | |||
| Open | High | Low | Value | Volume |
| $288.40 | $289.45 | $287.63 | $178.7M | 622.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 230 | $289.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $289.23 | 328 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$289.06 |
Change
1.140 ( 0.53 %) |
||||
| Open | High | Low | Volume | ||
| $288.42 | $289.39 | $287.61 | 103055 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| CSL (ASX) Chart |